Invest in Cannabis

Invest in Cannabis Australia with MOCA.

Cannabis and Marijuana were once words that described a prohibited drug that was synonymous with the hippy movement. Today cannabis is considered one of the leading emerging medications which hold high promise for good health and healing. Moreover, investing in cannabis in Australian and New Zealand is now one of the hottest opportunities on the market and once again for good reason. On this site we will explore these two facts and reveal an exciting investment opportunity to enter at ground level in one of the most comprehensive cannabis companies in the world.

Why is Cannabis now considered medicine?

One of the most astounding discoveries of the 20th century began when Israeli Scientist Dr Raphael Mechoulam isolated the first cannabinoid in the cannabis plant in the 1960's, the doctor was looking at the component that makes people 'high'. With this first discovery, the doorway opened into the research of what these cannabinoids are and how they affect humans. In the 1980's a huge leap in human heal and well being occurred when, as a consequence of the cannabis research, scientists discovered that humans have a endocannabinoid system. This one system is now understood to be the singular most important regulator of health.  In fact the role of the endocannabinoid system is to monitor and adjust homeostasis. 

What is interesting about this system is that firstly all humans have one and also, so do all animals. This system is through out our bodies and is covered in receptors. It is these receptors that respond to the cannabinoids in cannabis and create healing and wellness.  There are over 100 cannabinoids in the cannabis plants, and only one has the psychotropic effects (THC), All have healing properties and when taken as a whole plant therapy, produce what is known as the 'entourage effect'.   

Understanding these key concepts is fundamental to understanding why cannabis has been described as a 'once in a generation' opportunity. In short, various cannabis extracts will one day be present in almost all products designed for human consumption, from cosmetics, to beverages to foods. And of course for pets and livestock as well.

Invest in Cannabis Australia

Cannabis Investments Around the World. Investing in the Australian and New Zealand Cannabis Markets 

Enter the Cannabis Investment Market on the Ground Floor. It is our ambition to brand and market the highest quality, legal cannabis & hemp products.

Medicinal Organic Cannabis Australia (MOCA) Our Vision and Philosophy

MOCA is Australia's leading organic cannabis wholesaler company and has international ties with global leaders in the organic marijuana industry.

Invest in Cannabis in New Zealand - The booming Marijuana Investment Market.

The Cannabis industry is booming and you can invest in the New Zealand marijuana industry.

The Growth Of the Marijuana Industry Worldwide

The industry globally is expanding exponentially and will continue to grow for the next 10 years. 

Publicly Listed ASX Cannabis Shares take a hit. 

15th October 2019

It certainly has been a disappointing day of trade for a number of ASX cannabis shares.

Three ASX Cannabis Companies have just tumbled to 52-week lows or worse. 

The AusCann Group Holdings Ltd (ASX: AC8) share price has crashed to a two-year low of 26 cents on Tuesday. This means that the cannabis company’s shares are now trading within sight of their IPO price of 20 cents. Investors have been heading to the exits in their droves after its major shareholder and strategic partner, Canopy Growth Corp, dumped its entire 13.2% stake. Whilst the two parties intend to work together in the future, the sale of its stake certainly is an ominous sign.

Invest In Cannabis

The Creso Pharma Ltd (ASX: CPH) share price sank to a two-year low of 28 cents this morning. This decline appears to be down to concerns over the PharmaCielo takeover. The Canada-listed cannabis company is in the process of taking over Creso Pharma in an all-scrip deal. 

THC Global Group Ltd (ASX: THC) share price dropped to a two-year low of 41 cents this morning. Last month this cannabis company revealed that it has secured an agreement to lease a property with 66,000m2 of existing hydroponics greenhouses, and an additional 180,000m2 of agricultural land for the cultivation of medicinal cannabis in Bundaberg, Queensland.  Read More